Compared with euthyroidism, SCH is not associated with an increased risk of atrial fibrillation in patients undergoing CABG. It is associated with an increased risk of several minor perioperative problems, which should be anticipated and preemptively managed.
Keyphrases
- patients undergoing
- coronary artery bypass
- atrial fibrillation
- percutaneous coronary intervention
- coronary artery disease
- minimally invasive
- mental health
- coronary artery
- coronary artery bypass grafting
- oral anticoagulants
- catheter ablation
- left atrial
- cardiac surgery
- heart failure
- direct oral anticoagulants
- left atrial appendage
- replacement therapy
- type diabetes
- acute coronary syndrome
- venous thromboembolism
- metabolic syndrome
- weight loss